Novartis AG
BMV:NVSN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Novartis AG
BMV:NVSN
|
CH |
|
A
|
ASML Holding NV
XMUN:ASME
|
NL |
|
H
|
HDFC Life Insurance Company Ltd
BSE:540777
|
IN |
|
Clemondo Group AB (publ)
F:N170
|
SE |
|
K
|
Krystal Biotech Inc
SWB:4KB
|
US |
|
U
|
United Airlines Holdings Inc
XMUN:UAL1
|
US |
|
A
|
Ad Pepper Media International NV
F:APM
|
DE |
|
News Corp
F:NC0E
|
US |
|
Wolters Kluwer NV
AEX:WKL
|
NL |
|
B
|
Brown & Brown Inc
XMUN:BTW
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NVSN's stock price target?
Price Target
2 727.14
MXN
According to Wall Street analysts, the average 1-year price target for 
NVSN is 2 727.14 MXN with a low forecast of 2 166.21 MXN and a high forecast of 3 279.61 MXN.
What is the Revenue forecast for Novartis AG?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 8 years is 3%.
What is the Gross Profit forecast for Novartis AG?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 1%. The projected CAGR for the next 8 years is 4%.
What is the Operating Income forecast for Novartis AG?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 8 years is 6%.
What is the Pre-Tax Income forecast for Novartis AG?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 3%. The projected CAGR for the next 3 years is 14%.
What is the Net Income forecast for Novartis AG?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Net Income has been 3%. The projected CAGR for the next 8 years is 7%.